Sandy Decosterd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandy Decosterd has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Manuela Eicher
Institute of Higher Education and Research in Healthcare, Faculty of Biology and Medicine, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland
2 shared publications - Pierre-Yves Dietrich
Center for Translational Research in Onco-Hematology, Department of Oncology, University Hospital of Geneva, University of Geneva, Swiss Cancer Center Leman (SCCL), Agora Cancer Research Center, Geneva, Switzerland
2 shared publications Andrea Serena
Centre hospitalier universitaire vaudois, BU 21 06 223, rue du Bugnon 46, 1011 Lausanne, Suisse
1 shared publication- Andreas Samuel Ebneter
University Center for Palliative Care, University Hospital, Inselspital Bern, Switzerland
1 shared publication André Da Silva Lopes
Institute of Higher Education and Research in Healthcare (IUFRS) Faculty of Biology and Medicine, University of Lausanne Lausanne Switzerland
1 shared publication- Anne Gerber
School of Health Sciences (HESAV) University of Applied Sciences and Arts Western Switzerland (HES‐SO) Lausanne Switzerland
1 shared publication
Latest Publications
- 4 August 2022
- Published by Elsevier in Revue Francophone Internationale de Recherche Infirmière
- Vol. 8 (2) , 100269
Les croyances, barrières et facilitateurs à l’adhésion thérapeutique des patients sous traitements anticancéreux oraux de thérapie ciblée orale : une étude qualitative exploratoire bicentrique en Suisse romande
- 4 August 2022
- Published by Elsevier in Revue Francophone Internationale de Recherche Infirmière
- Vol. 8 (2) , 100269
Les croyances, barrières et facilitateurs à l’adhésion thérapeutique des patients sous traitements anticancéreux oraux de thérapie ciblée orale : une étude qualitative exploratoire bicentrique en Suisse romande
- Open Access
- 12 May 2020
- Published by Wiley in Health Science Reports
- Vol. 3 (2) , e160
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool
Background and aims: The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in Switzerland remains unknown. The primary objective of this study was to describe, for the first time, the occurrence rate, type, severity of harm, and preventability of AEs related to care, reported in health records of hospitalized hematological and solid‐tumor cancer patients in three Swiss hospitals.Methods: Using an adapted version of the validated Global Trigger Tool (GTT) from the Institute for Healthcare Improvement, we conducted a retrospective record review of patients discharged from oncology units over a 6‐week period during 2018. Our convenience sample included all records from adult patients (≥18 years of age), diagnosed with cancer, and hospitalized (>24 hours). Per the GTT method, two trained nurses independently assessed patient records to identify AEs using triggers, and physicians from the included units analyzed the consensus of the two nurses. Together, they assessed the severity and preventability of each AE.Results: From the sample of 224 reviewed records, we identified 661 triggers and 169 AEs in 94 of them (42%). Pain related to care was the most frequent AE (n = 29), followed by constipation (n = 17). AEs rates were 75.4 per 100 admissions and 106.6 per 1000 patient days. Most of the identified AEs (78%) caused temporary harm to the patient and required an intervention. Among AEs during hospitalization (n = 125), 76 (61%) were considered not preventable, 28 (22%) preventable, and 21 (17%) undetermined.Conclusion: About half of the hospitalized oncology patients suffered from at least one AE related to care during their hospitalization. Pain, constipation, and nosocomial infections were the most frequent AEs. It is, therefore, essential to identify AEs to guide future clinical practice initiatives to ensure patient safety.
- 12 May 2020
- Published by Wiley in Health Science Reports
- Vol. 3 (2) , e160
Open AccessDescribing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool
Background and aims: The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in Switzerland remains unknown. The primary objective of this study was to describe, for the first time, the occurrence rate, type, severity of harm, and preventability of AEs related to care, reported in health records of hospitalized hematological and solid‐tumor cancer patients in three Swiss hospitals.Methods: Using an adapted version of the validated Global Trigger Tool (GTT) from the Institute for Healthcare Improvement, we conducted a retrospective record review of patients discharged from oncology units over a 6‐week period during 2018. Our convenience sample included all records from adult patients (≥18 years of age), diagnosed with cancer, and hospitalized (>24 hours). Per the GTT method, two trained nurses independently assessed patient records to identify AEs using triggers, and physicians from the included units analyzed the consensus of the two nurses. Together, they assessed the severity and preventability of each AE.Results: From the sample of 224 reviewed records, we identified 661 triggers and 169 AEs in 94 of them (42%). Pain related to care was the most frequent AE (n = 29), followed by constipation (n = 17). AEs rates were 75.4 per 100 admissions and 106.6 per 1000 patient days. Most of the identified AEs (78%) caused temporary harm to the patient and required an intervention. Among AEs during hospitalization (n = 125), 76 (61%) were considered not preventable, 28 (22%) preventable, and 21 (17%) undetermined.Conclusion: About half of the hospitalized oncology patients suffered from at least one AE related to care during their hospitalization. Pain, constipation, and nosocomial infections were the most frequent AEs. It is, therefore, essential to identify AEs to guide future clinical practice initiatives to ensure patient safety.